JP2012522037A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522037A5
JP2012522037A5 JP2012502770A JP2012502770A JP2012522037A5 JP 2012522037 A5 JP2012522037 A5 JP 2012522037A5 JP 2012502770 A JP2012502770 A JP 2012502770A JP 2012502770 A JP2012502770 A JP 2012502770A JP 2012522037 A5 JP2012522037 A5 JP 2012522037A5
Authority
JP
Japan
Prior art keywords
biofilm
infection
product
agent
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012502770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522037A (ja
JP5727994B2 (ja
Filing date
Publication date
Priority claimed from GBGB0905451.1A external-priority patent/GB0905451D0/en
Application filed filed Critical
Publication of JP2012522037A publication Critical patent/JP2012522037A/ja
Publication of JP2012522037A5 publication Critical patent/JP2012522037A5/ja
Application granted granted Critical
Publication of JP5727994B2 publication Critical patent/JP5727994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012502770A 2009-03-31 2010-03-31 バイオフィルム生物の阻害 Active JP5727994B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16539609P 2009-03-31 2009-03-31
GB0905451.1 2009-03-31
US61/165,396 2009-03-31
GBGB0905451.1A GB0905451D0 (en) 2009-03-31 2009-03-31 Biofilms
PCT/GB2010/000631 WO2010112848A2 (en) 2009-03-31 2010-03-31 Inhibition of biofilm organisms

Publications (3)

Publication Number Publication Date
JP2012522037A JP2012522037A (ja) 2012-09-20
JP2012522037A5 true JP2012522037A5 (https=) 2013-05-16
JP5727994B2 JP5727994B2 (ja) 2015-06-03

Family

ID=40671951

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012502770A Active JP5727994B2 (ja) 2009-03-31 2010-03-31 バイオフィルム生物の阻害

Country Status (21)

Country Link
US (3) US9339525B2 (https=)
EP (1) EP2413949B1 (https=)
JP (1) JP5727994B2 (https=)
KR (1) KR101852784B1 (https=)
CN (2) CN104257645A (https=)
AU (2) AU2010231136B2 (https=)
BR (1) BRPI1012219C1 (https=)
CA (1) CA2755878C (https=)
CY (1) CY1121175T1 (https=)
GB (1) GB0905451D0 (https=)
IL (1) IL215369B2 (https=)
MX (1) MX358018B (https=)
NZ (1) NZ595037A (https=)
PL (1) PL2413949T3 (https=)
RU (1) RU2548786C2 (https=)
SG (2) SG10201400926VA (https=)
SI (1) SI2413949T1 (https=)
TR (1) TR201821161T4 (https=)
UA (1) UA106743C2 (https=)
WO (1) WO2010112848A2 (https=)
ZA (1) ZA201107140B (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
TWI403330B (zh) * 2010-03-29 2013-08-01 Rise technology co ltd 低血球溶解性之抗微生物胜肽、醫藥組成物及其用途
GB201016733D0 (en) * 2010-10-05 2010-11-17 Novabiotics Ltd Compounds and their use
SG184836A1 (en) 2010-04-27 2012-11-29 Lysando Ag Method of reducing biofilms
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
CN103687610A (zh) 2011-05-12 2014-03-26 史密夫和内修整形外科股份公司 含有蜂蜜曲霉蛋白酶的伤口清创组合物和使用其治疗伤口的方法
TWI415572B (zh) 2011-06-17 2013-11-21 Univ Chang Gung 利用１，２，３，４，６－五－ｏ－沒食子醯基－ｄ－葡哌喃糖來抑制生物膜形成
US20140315789A1 (en) * 2011-11-23 2014-10-23 Newsouth Innovations Pty Limited Antimicrobial peptides and uses thereof
ES2991989T3 (es) * 2012-03-23 2024-12-05 Macro Biologics Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con tejidos
WO2013170128A1 (en) 2012-05-11 2013-11-14 Smith & Nephew, Inc. Use of seaprose to remove bacterial biofilm
WO2014016979A1 (ja) * 2012-07-27 2014-01-30 住友重機械工業株式会社 微生物活性調節剤及び微生物の活性を調節する方法
US20160289287A1 (en) * 2013-08-27 2016-10-06 The University Of British Columbia Small cationic anti-biofilm and idr peptides
GB201405891D0 (en) * 2014-04-02 2014-05-14 Novabiotics Ltd Modified antimicrobial peptides
GB201416727D0 (en) * 2014-09-22 2014-11-05 Novabiotics Ltd Use
US20160102052A1 (en) * 2014-09-22 2016-04-14 Novabiotics Limited Use of Cysteamine in Treating Infections caused by Yeasts/Moulds
GB201510077D0 (en) * 2015-06-10 2015-07-22 Novabiotics Ltd Use
US11103547B2 (en) 2016-02-04 2021-08-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
US20210213096A1 (en) * 2016-02-19 2021-07-15 Forschungszentrum Borstel Leibniz-Zentrum Fur Medizin Und Biowssenschaften Means and methods for treating bacterial infections
WO2017176796A1 (en) 2016-04-04 2017-10-12 University Of Virginia Patent Foundation Compositions and methods for preventing and treating disease
EP3241570A1 (en) * 2016-05-02 2017-11-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptide and hyaluronic acid coatings
EP3454876A4 (en) * 2016-05-12 2019-11-20 The Trustees of The University of Pennsylvania Compositions and methods for inhibiting biofilm deposition and production
WO2017212239A1 (en) * 2016-06-07 2017-12-14 Novabiotics Limited Treatment of drug-resistant microbial infections
AU2017304271B2 (en) 2016-07-27 2024-07-18 Smith & Nephew, Inc. Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
DK3554491T3 (en) 2016-12-15 2023-05-15 Zambon Spa N-acetylcystein til anvendelse som antibakterielt middel
AU2017381394A1 (en) * 2016-12-22 2019-07-25 The University Of Sydney Biofilm disrupting composition
AU2018205685B2 (en) * 2017-01-05 2023-03-16 Cormedix Inc. Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilms
EP3573622B1 (en) 2017-01-30 2023-10-18 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
US11285189B2 (en) 2017-04-06 2022-03-29 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
RU2664708C1 (ru) * 2017-06-08 2018-08-21 Сергей Иванович Черныш Способ разрушения и предотвращения образования бактериальных биопленок комплексом антимикробных пептидов насекомых
CN108048359B (zh) * 2017-12-27 2020-12-01 广州立白企业集团有限公司 一种牙菌斑生物膜模型的培养方法和优化的生物膜活菌计数法及应用
EP3765057A4 (en) * 2018-03-13 2022-01-05 Peptilogics, Inc. TREATMENT OF IMPLANTS WITH GENERALLY MODIFIED AMPHIPHILIC PEPTIDES
CN108753632A (zh) * 2018-05-25 2018-11-06 安徽中医药大学 一种溶解白念珠菌生物被膜胞外基质的方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3866775B1 (en) * 2018-10-17 2025-03-19 Novabiotics Limited Cysteamine for use in the treatment of lung diseases
CN110402928A (zh) * 2019-08-08 2019-11-05 杭州博菲医疗器械有限公司 一种抑菌功能液及应用该抑菌功能液的导管组件
CN110583697B (zh) * 2019-09-20 2021-04-06 浙江工商大学 去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用
CN111675751B (zh) * 2020-04-08 2022-06-14 天津医科大学口腔医院 一种抗菌肽及其应用
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
US12371463B2 (en) 2021-04-20 2025-07-29 University of Pittsburgh—of the Commonwealth System of Higher Education Methods and compositions for treatment of antibiotic-resistant bacterial infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055560B (it) * 1974-05-02 1982-01-11 Istituto Chemioterapico Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
AU2042200A (en) * 1998-12-07 2000-06-26 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
ITMI20021881A1 (it) * 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
PL1778720T3 (pl) * 2004-08-18 2011-03-31 Novabiotics Ltd Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę
WO2007050565A2 (en) 2005-10-25 2007-05-03 Baylor College Of Medicine Incorporation of antimicrobial combinations onto devices to reduce infection
ZA200805191B (en) * 2005-11-28 2009-08-26 Hk Omega Biopharma Ltd Materials and methods for treating viral infections with a cysteamine compound
AR057623A1 (es) * 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
GB0702021D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
CN101842092A (zh) * 2007-05-25 2010-09-22 奥碧医药(香港)有限公司 用于治疗流感感染的材料和方法
BRPI0907561A2 (pt) * 2008-02-17 2015-08-04 Walcom Animal Science I P 3 Ltd Materiais e métodos para aperfeiçoamento da saúde de camarões
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
GB201021186D0 (en) * 2010-12-14 2011-01-26 Novabiotics Ltd Composition
US20160102052A1 (en) * 2014-09-22 2016-04-14 Novabiotics Limited Use of Cysteamine in Treating Infections caused by Yeasts/Moulds
US20160106689A1 (en) * 2014-09-22 2016-04-21 Novabiotics Limited Use

Similar Documents

Publication Publication Date Title
JP2012522037A5 (https=)
RU2011143399A (ru) Ингибирование организмов биопленки
ES2565564T3 (es) Una composición que comprende un antibiótico y un dispersante
US11096992B2 (en) Use of seaprose to remove bacterial biofilm
CN101573031A (zh) 抗微生物组合物
MX2008009605A (es) Uso del galio para tratar infecciones asociadas con una biopelicula.
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
MX2011010258A (es) Inhibicion de organismos de biopelicula.
JP2005511642A5 (https=)
CN101578045A (zh) 抗微生物组合物
US11779559B2 (en) Compositions for treating fungal and bacterial biofilms and methods of using the same
US20250144060A1 (en) Compositions and methods for treating biofilms
RU2012149863A (ru) Полисахарид семени тамаринда для применения в лечении микробных инфекций
US9480669B2 (en) Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
US20180153840A1 (en) The compositions of glycerol and /or non-toxic amino acids for inhibiting and destroying biofilm, including related methods
WO2019215285A1 (en) Substituted cyclodextrin-metal complexes and uses thereof
WO2022079315A1 (fr) Composition para-pharmaceutique ou pharmaceutique administrable à un être vivant, de préférence un être humain comprenant au moins une enzyme pour le traitement et/ou la prévention d'infections bactériennes impliquant la formation de biofilm
WO2009070564A3 (en) Compositions and methods for prevention of infection in transcutaneous osseointegrated implants
US12109176B1 (en) Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives
WO2006012146A3 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
WO2009077485A3 (en) 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents
FR3072279A1 (fr) Utilisation de la cloxacilline pour inhiber/ empecher la formation de biofilm